about
Hypothesis testing in high-throughput screening for drug discovery.Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery.Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells.Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells.Real-time cellular impedance measurements detect Ca(2+) channel-dependent oscillations of morphology in human H295R adrenoma cells.Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells.Diffusion-time distribution analysis reveals characteristic ligand-dependent interaction patterns of nuclear receptors in living cells.MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients.Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass.White-to-brown metabolic conversion of human adipocytes by JAK inhibition.Coupled rotation within single F0F1 enzyme complexes during ATP synthesis or hydrolysis.Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.Post-translational covalent labeling reveals heterogeneous mobility of individual G protein-coupled receptors in living cells.A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancerThree-dimensional optical polarization tomography of single moleculesOrientation dependence of fluorescence lifetimes near an interfaceSingle-Molecule Identification by Spectrally and Time-Resolved Fluorescence DetectionMachine learning-powered antibiotics phenotypic drug discoveryEnhancing gene set enrichment using networksMultiparameter microscopy and spectroscopy for single-molecule analyticsImmunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
P50
Q34123122-A762B464-51CB-4F6C-BB31-124F8A0B10E4Q34555711-BC8542E7-0F34-42D3-8646-E46B0C51D297Q35463524-2FCC58D4-86CB-4753-B8A7-8E9492103A0BQ36051205-8CCC978C-15D0-4DE2-9AA3-3BDF67F50F5CQ39603726-A79DA185-49A4-4E19-898E-2F3C8C16F60EQ40254481-142D05D3-1CA1-48E2-AC7F-D99F11691FEEQ40380394-67DD53C9-7137-4276-8B50-7A2804EECD2AQ42317002-90DE2A85-7867-477E-A541-4113D6B16EFCQ42482084-97F1ECCE-AEB5-4F4A-B76D-71E0ED144C70Q42726932-30C27AD1-02BA-4666-9792-16F31F782F46Q42972519-A8BC01F2-B1DA-4883-9AA8-D71D9F59DFFEQ44090533-E89A22FB-0A29-432D-9109-6D87B9030384Q44316914-904723F2-24C6-4E6E-B59D-E2A5B3194170Q51228218-EB27CCB1-3514-4C3B-BAC5-0412E7E934F5Q61446009-8FA2E9DD-AA07-477F-9C37-E3730F500A99Q62044221-5A5FCC79-B58D-4C21-9F0A-8E65316D3265Q62044229-7E8EE903-4EC8-460D-8049-F9B86C501044Q62044237-6D01B2FC-3C15-46A5-911E-37DA543BCC9AQ64068066-00221458-6219-42DB-A61F-0330E0C5692EQ64293656-E6C80EE8-1A09-4D53-8245-4D07AA384692Q79772620-376FB73D-C2C6-4743-A4D9-41DA88BB3A89Q91596650-66CEE1EB-104F-4A75-AC23-36382C76600A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Prummer
@ast
Michael Prummer
@en
Michael Prummer
@es
Michael Prummer
@nl
Michael Prummer
@sl
type
label
Michael Prummer
@ast
Michael Prummer
@en
Michael Prummer
@es
Michael Prummer
@nl
Michael Prummer
@sl
prefLabel
Michael Prummer
@ast
Michael Prummer
@en
Michael Prummer
@es
Michael Prummer
@nl
Michael Prummer
@sl
P1053
G-6464-2011
P106
P21
P31
P3829
P496
0000-0001-9896-3929